trolamine salicylate has been researched along with Chronic Bronchitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aeberli, D; Jordi, B; Mauron, H; Oertle, S; Reichenbach, S; Villiger, PM | 1 |
1 trial(s) available for trolamine salicylate and Chronic Bronchitis
Article | Year |
---|---|
Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Autoimmune Diseases; Behcet Syndrome; Bronchitis, Chronic; Chronic Disease; Etanercept; Female; Granulomatosis with Polyangiitis; Humans; Immunoglobulin G; Infliximab; Keratosis; Male; Middle Aged; Radiography; Receptors, Tumor Necrosis Factor; Remission Induction; Scleritis; Signal Transduction; Still's Disease, Adult-Onset; Syndrome; Tracheitis; Tumor Necrosis Factor-alpha | 2002 |